Abstract
Objective: To report the survival of fungal sepsis in extracorporeal membrane oxygenation. Design: Single case report. Setting: Tertiary referral children's hospital pediatric intensive care unit. Patients: A single case report of an infant with congenital heart disease who developed candida sepsis while supported postoperatively with extracorporeal membrane oxygenation. Results: This infant survived a prolonged episode of candidemia after repair of congenital heart disease, which required extracorporeal membrane oxygenation support. The patient has no identified sequelae at 6-month follow-up and continues on long-term fluconazole therapy for Candida endocarditis. Conclusions: Candidemia, particularly Candida albicans species, may not be a contraindication for extracorporeal membrane oxygenation support. With antifungal therapy and adequate inotropic use to counter the effects of septicemia, survival can be maintained until the patient adequately recovers, allowing decannulation, removal of all catheters, and eventual bloodstream sterility.
Original language | English (US) |
---|---|
Pages (from-to) | 709-711 |
Number of pages | 3 |
Journal | Pediatric Critical Care Medicine |
Volume | 6 |
Issue number | 6 |
DOIs | |
State | Published - Nov 2005 |
Keywords
- Amphotericin B
- Candida albicans
- Congenital heart defect
- Endocarditis
- Extracorporeal membrane oxygenation
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Critical Care and Intensive Care Medicine